Tag: Life SciVC
An 18 Month Journey From Inception To IPO
By Ivana Magovčević-Liebisch PhD, JD, CEO of VIGIL NEUROSCIENCE, as part of the From The Trenches feature of LifeSciVC
Compared to most industries, biotech life...
Breaking News
Mind Meld: How Intellectually Diverse Teams Can Drive Resilience And Better Outcomes
By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC
Biotechnology, especially of late, requires us to prevail...
Breaking Up Is Hard To Do – But It Doesn’t Have To Be!
By Your Friendly Neighborhood Biotech CEO, as part of the From The Trenches feature of LifeSciVC (… an Anonymous CEO)
As one thinks about the...
Lessons Learned on Preparing to Weather the Inevitable Challenges in Biotech
By Joshua Brumm, CEO of Dyne Therapeutics, as part of the From The Trenches feature of LifeSciVC
By all accounts, 2022 did not start according...
How Remix Built A Science-Driven And Transparent Culture
By Peter Smith, co-founder and CEO, Remix Therapeutics, as part of the From The Trenches feature of LifeSciVC
One of the joys of starting a...
You Can’t Do It Alone – The Importance of Riding the Same Bus
By Ivana Magovcevic-Liebisch, CEO of Vigil Neuroscience, as part of the From The Trenches feature of LifeSciVC
From academic research, patent law, business development, to...
Surprising Resilience Of Private VC-Backed Biotech Markets
It’s biotech armageddon out there: with massive value destruction across public stocks, it’s clearly the worst market backdrop in over 20 years.
Nothing like this...
This Too Shall Pass
By Robert Clarke, CEO of Kinaset, as part of the From The Trenches feature of LifeSciVC.
Although I intend to shy away from the cult...
Hacking the Human Cell – How Once ‘Un-druggable’ Proteins Became the New Frontier in Drug Development
By Jonathan Montagu, CEO and founder of HotSpot Therapeutics, as part of the From The Trenches feature of LifeSciVC.
White Hat Hackers, sometimes called “ethical...
International Partnerships in Biotech: How Small Details Can Have a Big Impact
By Deanna Petersen, CBO of AVROBIO, and Ted Tanaka, consultant with Tanaka International LLC, as part of the From The Trenches feature of LifeSciVC
Imagine...
Leading With Head And Heart – Navigating The Human Side Of Tough Decisions
By Ankit Mahadevia, CEO of Spero Therapeutics, as part of the From The Trenches feature of LifeSciVC
2022 has brought unique challenges for growing companies....
The Courage of Patients in Phase 1 Cancer Trials
By René Russo, CEO of Xilio Therapeutics, as part of the From The Trenches feature of LifeSciVC
I had the opportunity to witness true courage...
Out On The (Cutting) Edge: How The Tools Of Extreme Survival Can Help Build A Biotech Company
By Aoife Brennan, CEO of Synlogic, as part of the From The Trenches feature of LifeSciVC
A couple of years ago, my husband returned from...